Red White & Bloom Brands Inc. (CSE:RWB)
Canada · Delayed Price · Currency is CAD 0.0350
0.00 (0.00%)
Jul 3, 2025, 9:30 AM EDT
Augmedix Income Statement
Financials in millions CAD. Fiscal year is January - December.
Millions CAD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2017 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2017 - 2019 |
| 80.17 | 69.57 | 87.71 | 37.27 | 19.27 | Upgrade | |
Revenue Growth (YoY) | 15.23% | -20.69% | 135.38% | 93.42% | - | Upgrade |
Cost of Revenue | 51.72 | 44.53 | 65.04 | 14.05 | 6.37 | Upgrade |
Gross Profit | 28.45 | 25.04 | 22.67 | 23.22 | 12.9 | Upgrade |
Selling, General & Admin | 33.26 | 19.83 | 24.81 | 30.06 | 11.5 | Upgrade |
Other Operating Expenses | - | - | 0.06 | 0.74 | - | Upgrade |
Operating Expenses | 40.4 | 31.03 | 32.28 | 56.7 | 26.32 | Upgrade |
Operating Income | -11.96 | -5.99 | -9.61 | -33.48 | -13.42 | Upgrade |
Interest Expense | -39.46 | -32.62 | -22.45 | -28.25 | -15.85 | Upgrade |
Interest & Investment Income | 1.18 | 3.04 | - | 2.06 | 4.1 | Upgrade |
Currency Exchange Gain (Loss) | 17.15 | 5.25 | -3.18 | -1.24 | -1.68 | Upgrade |
Other Non Operating Income (Expenses) | -0.98 | 1.68 | -1.01 | 13.18 | 60 | Upgrade |
EBT Excluding Unusual Items | -34.06 | -28.65 | -36.26 | -47.73 | 33.14 | Upgrade |
Merger & Restructuring Charges | -0.47 | -0.49 | - | - | - | Upgrade |
Impairment of Goodwill | - | - | -185.22 | - | - | Upgrade |
Gain (Loss) on Sale of Investments | 7.56 | - | - | - | - | Upgrade |
Gain (Loss) on Sale of Assets | 0.28 | -0 | -0.02 | - | - | Upgrade |
Asset Writedown | - | - | -29.54 | - | - | Upgrade |
Other Unusual Items | 0.71 | 0.65 | 11.74 | 8.74 | -43.36 | Upgrade |
Pretax Income | -25.99 | -28.5 | -239.31 | -38.99 | -10.22 | Upgrade |
Income Tax Expense | 0.05 | 17.78 | 3.48 | 0.16 | 0.2 | Upgrade |
Earnings From Continuing Operations | -26.04 | -46.28 | -242.79 | -39.15 | -10.43 | Upgrade |
Earnings From Discontinued Operations | -7.05 | -93.44 | 0.66 | -44.2 | -8.15 | Upgrade |
Net Income to Company | -33.1 | -139.72 | -242.13 | -83.35 | -18.58 | Upgrade |
Minority Interest in Earnings | 6.88 | 4.05 | 6.36 | -0.27 | - | Upgrade |
Net Income | -26.21 | -135.67 | -235.77 | -83.62 | -18.58 | Upgrade |
Net Income to Common | -26.21 | -135.67 | -235.77 | -83.62 | -18.58 | Upgrade |
Shares Outstanding (Basic) | 470 | 470 | 392 | 218 | 138 | Upgrade |
Shares Outstanding (Diluted) | 470 | 470 | 392 | 218 | 138 | Upgrade |
Shares Change (YoY) | 0.06% | 19.75% | 80.19% | 58.32% | 70.47% | Upgrade |
EPS (Basic) | -0.06 | -0.29 | -0.60 | -0.38 | -0.14 | Upgrade |
EPS (Diluted) | -0.06 | -0.29 | -0.60 | -0.38 | -0.14 | Upgrade |
Free Cash Flow | -15.59 | -80.85 | -27.35 | -56.56 | -45.27 | Upgrade |
Free Cash Flow Per Share | -0.03 | -0.17 | -0.07 | -0.26 | -0.33 | Upgrade |
Gross Margin | 35.48% | 36.00% | 25.85% | 62.30% | 66.96% | Upgrade |
Operating Margin | -14.91% | -8.61% | -10.96% | -89.84% | -69.68% | Upgrade |
Profit Margin | -32.70% | -195.01% | -268.79% | -224.40% | -96.42% | Upgrade |
Free Cash Flow Margin | -19.44% | -116.21% | -31.18% | -151.77% | -234.95% | Upgrade |
EBITDA | -7.38 | -2.68 | -5.35 | -12.47 | -2.56 | Upgrade |
EBITDA Margin | -9.21% | -3.85% | -6.10% | -33.45% | -13.27% | Upgrade |
D&A For EBITDA | 4.58 | 3.31 | 4.27 | 21.01 | 10.87 | Upgrade |
EBIT | -11.96 | -5.99 | -9.61 | -33.48 | -13.42 | Upgrade |
EBIT Margin | -14.91% | -8.61% | -10.96% | -89.84% | -69.68% | Upgrade |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.